BellRing Brands: Capitalizing on Health and Wellness Growth
Updated
BellRing Brands has broken out of a stage-one double-bottom base, signaling strong technical action and providing a compelling entry point. As a leading company in the health and wellness industry, BellRing Brands is well-positioned to benefit from the increasing demand for ready-to-drink protein shakes and nutrition bars. This breakout suggests a strong potential for further upside.
Technical Overview:
The stock has seen accumulation over the past several weeks, bouncing off the 21-day EMA and currently trading near highs. Using the IBD base pattern methodology, we aim for a 20% profit target, with an 8% stop loss to manage risk.
Profit Target: $75.96, reflecting a 20% gain from current levels.
Stop Loss: $58.65, which is approximately 8% below the entry point.
Squeeze Indicator:
The MTF Squeeze Analyzer [tradeviZion] confirms that a squeeze has fired on both the daily and weekly timeframes. This indicates that volatility is expanding, supporting further price acceleration and aligning with the breakout setup.
Momentum and Market Overview:
With the MTF SqzMom [tradeviZion] Indicator, we observe that momentum is in an uptrend for the 4H and higher time frames (W, 4D, and 2D).
The current RS Rating is 87, further confirming its relative strength in the market.
Final Thoughts:
BellRing Brands offers a strong opportunity for growth investors, driven by solid fundamentals and technical strength. The 20% target aligns with IBD’s proven methodology, while the tools provided by TradeVizion, including the Squeeze Analyzer and MTF sqzMom, provide additional layers of confirmation for timing and managing the trade.
Leverage the advanced insights from TradeVizion’s to improve your trading strategies with clarity and confidence.
Technical Overview:
The stock has seen accumulation over the past several weeks, bouncing off the 21-day EMA and currently trading near highs. Using the IBD base pattern methodology, we aim for a 20% profit target, with an 8% stop loss to manage risk.
Profit Target: $75.96, reflecting a 20% gain from current levels.
Stop Loss: $58.65, which is approximately 8% below the entry point.
Squeeze Indicator:
The MTF Squeeze Analyzer [tradeviZion] confirms that a squeeze has fired on both the daily and weekly timeframes. This indicates that volatility is expanding, supporting further price acceleration and aligning with the breakout setup.
Momentum and Market Overview:
With the MTF SqzMom [tradeviZion] Indicator, we observe that momentum is in an uptrend for the 4H and higher time frames (W, 4D, and 2D).
The current RS Rating is 87, further confirming its relative strength in the market.
Final Thoughts:
BellRing Brands offers a strong opportunity for growth investors, driven by solid fundamentals and technical strength. The 20% target aligns with IBD’s proven methodology, while the tools provided by TradeVizion, including the Squeeze Analyzer and MTF sqzMom, provide additional layers of confirmation for timing and managing the trade.
Leverage the advanced insights from TradeVizion’s to improve your trading strategies with clarity and confidence.
Trade closed: target reached
Trade Status Update: Targets Exceeded
The BellRing Brands (BRBR) trade idea has significantly outperformed expectations, with the stock reaching new 52-week highs and exceeding the original profit target.
Original Trade Parameters:
Entry Point: Around $63.30
Profit Target: $75.96
Stop Loss: $58.65
Current Performance:
Current Price: $76.18 (new 52-week high)
Gain from Entry: Approximately +20%
Original Target: ✓ Achieved
Trade Management:
Traders who followed the original idea should consider:
Taking partial profits at the original target
Trailing stops for remaining position to protect gains
Monitoring new resistance levels for additional profit targets
The trade has played out exceptionally well, supported by both technical breakout and fundamental strength in the company's performance.
TradeVizion™
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.